TY  - JOUR
AU  - Šuljagić, Vesna
AU  - Đurić-Petković, Danijela
AU  - Lazić, Srdan
AU  - Mladenović, Jovan
AU  - Rakonjac, Bojan
AU  - Opačić, Dolores
AU  - Ljubenović, Nenad
AU  - Milojković, Biljana
AU  - Radojević, Katarina
AU  - Nenezić, Ivana
AU  - Rančić, Nemanja
PY  - 2023
UR  - http://intor.torlakinstitut.com/handle/123456789/655
AB  - Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its resulting coronavirus disease 2019 (COVID-19) has caused a fast-moving pandemic. Diagnostic testing, aimed to identify patients infected with SARS-CoV-2, plays a key role in controlling the COVID-19 pandemic in different populations. (2) Methods: This retrospective cohort study aimed to investigate predictors associated with positive polymerase chain reaction (PCR) SARS-CoV-2 test results in hospitalized patients, healthcare workers (HCWs), and military personnel (MP) during 2020, before the widespread availability of COVID-19 vaccines. Persons with a positive test result were compared with persons with a negative test result in three cohorts during the study period. (3) Results: A total of 6912 respondents were tested, and 1334 (19.3%) of them had positive PCR SARS-CoV-2 test results. Contact with a known COVID-19 case within 14 days (p < 0.001; OR: 1.48; 95% CI: 1.25–1.76), fever (p < 0.001; OR: 3.66; 95% CI: 3.04–4.41), cough (p < 0.001; OR: 1.91; 95% CI: 1.59–2.30), headache (p = 0.028; OR: 1.24; 95% CI: 1.02–1.50), and myalgia/arthralgia (p < 0.001; OR: 1.99; 95% CI: 1.65–2.42) were independently associated with positive PCR SARS-CoV-2 test results in the cohort of MP. Furthermore, fever (p < 0.001; OR: 2.75; 95% CI: 1.83–4.13), cough (p < 0.001; OR: 2.04; 95% CI: 1.32–3.13), headache (p = 0.008; OR: 1.76; 95% CI: 1.15–2.68), and myalgia/arthralgia (p = 0.039; OR: 1.58; 95% CI: 1.02–2.45) were independently associated with positive PCR SARS-CoV-2 test results in the cohort of HCWs. Moreover, independent predictors of positive PCR SARS-CoV-2 test results in hospitalized patients were contact with a known COVID-19 case within 14 days (p < 0.001; OR: 2.56; 95% CI: 1.71–3.83), fever (p < 0.001; OR: 1.89; 95% CI: 1.38–2.59), pneumonia (p = 0.041; OR: 1.45; 95% CI: 1.01–2.09), and neurological diseases (p = 0.009; OR: 0.375; 95% CI: 0.18–0.78). (4) Conclusions: According to data gathered from cohorts of hospitalized patients, HCWs, and MP, before the widespread availability of COVID-19 vaccines in Serbia, we can conclude that predictors of positive PCR SARS-CoV-2 test results in MP and HCWs were similar. Accurate estimates of COVID-19 in different population groups are important for health authorities.
PB  - MDPI
T2  - International Journal of Environmental Research and Public Health
T1  - Epidemiological Predictors of Positive SARS-CoV-2 Polymerase Chain Reaction Test in Three Cohorts: Hospitalized Patients, Healthcare Workers, and Military Population, Serbia, 2020
IS  - 4
SP  - 3601
VL  - 20
DO  - 10.3390/ijerph20043601
ER  - 

@article{
author = "Šuljagić, Vesna and Đurić-Petković, Danijela and Lazić, Srdan and Mladenović, Jovan and Rakonjac, Bojan and Opačić, Dolores and Ljubenović, Nenad and Milojković, Biljana and Radojević, Katarina and Nenezić, Ivana and Rančić, Nemanja",
year = "2023",
abstract = "Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its resulting coronavirus disease 2019 (COVID-19) has caused a fast-moving pandemic. Diagnostic testing, aimed to identify patients infected with SARS-CoV-2, plays a key role in controlling the COVID-19 pandemic in different populations. (2) Methods: This retrospective cohort study aimed to investigate predictors associated with positive polymerase chain reaction (PCR) SARS-CoV-2 test results in hospitalized patients, healthcare workers (HCWs), and military personnel (MP) during 2020, before the widespread availability of COVID-19 vaccines. Persons with a positive test result were compared with persons with a negative test result in three cohorts during the study period. (3) Results: A total of 6912 respondents were tested, and 1334 (19.3%) of them had positive PCR SARS-CoV-2 test results. Contact with a known COVID-19 case within 14 days (p < 0.001; OR: 1.48; 95% CI: 1.25–1.76), fever (p < 0.001; OR: 3.66; 95% CI: 3.04–4.41), cough (p < 0.001; OR: 1.91; 95% CI: 1.59–2.30), headache (p = 0.028; OR: 1.24; 95% CI: 1.02–1.50), and myalgia/arthralgia (p < 0.001; OR: 1.99; 95% CI: 1.65–2.42) were independently associated with positive PCR SARS-CoV-2 test results in the cohort of MP. Furthermore, fever (p < 0.001; OR: 2.75; 95% CI: 1.83–4.13), cough (p < 0.001; OR: 2.04; 95% CI: 1.32–3.13), headache (p = 0.008; OR: 1.76; 95% CI: 1.15–2.68), and myalgia/arthralgia (p = 0.039; OR: 1.58; 95% CI: 1.02–2.45) were independently associated with positive PCR SARS-CoV-2 test results in the cohort of HCWs. Moreover, independent predictors of positive PCR SARS-CoV-2 test results in hospitalized patients were contact with a known COVID-19 case within 14 days (p < 0.001; OR: 2.56; 95% CI: 1.71–3.83), fever (p < 0.001; OR: 1.89; 95% CI: 1.38–2.59), pneumonia (p = 0.041; OR: 1.45; 95% CI: 1.01–2.09), and neurological diseases (p = 0.009; OR: 0.375; 95% CI: 0.18–0.78). (4) Conclusions: According to data gathered from cohorts of hospitalized patients, HCWs, and MP, before the widespread availability of COVID-19 vaccines in Serbia, we can conclude that predictors of positive PCR SARS-CoV-2 test results in MP and HCWs were similar. Accurate estimates of COVID-19 in different population groups are important for health authorities.",
publisher = "MDPI",
journal = "International Journal of Environmental Research and Public Health",
title = "Epidemiological Predictors of Positive SARS-CoV-2 Polymerase Chain Reaction Test in Three Cohorts: Hospitalized Patients, Healthcare Workers, and Military Population, Serbia, 2020",
number = "4",
pages = "3601",
volume = "20",
doi = "10.3390/ijerph20043601"
}

Šuljagić, V., Đurić-Petković, D., Lazić, S., Mladenović, J., Rakonjac, B., Opačić, D., Ljubenović, N., Milojković, B., Radojević, K., Nenezić, I.,& Rančić, N.. (2023). Epidemiological Predictors of Positive SARS-CoV-2 Polymerase Chain Reaction Test in Three Cohorts: Hospitalized Patients, Healthcare Workers, and Military Population, Serbia, 2020. in International Journal of Environmental Research and Public Health
MDPI., 20(4), 3601.
https://doi.org/10.3390/ijerph20043601

Šuljagić V, Đurić-Petković D, Lazić S, Mladenović J, Rakonjac B, Opačić D, Ljubenović N, Milojković B, Radojević K, Nenezić I, Rančić N. Epidemiological Predictors of Positive SARS-CoV-2 Polymerase Chain Reaction Test in Three Cohorts: Hospitalized Patients, Healthcare Workers, and Military Population, Serbia, 2020. in International Journal of Environmental Research and Public Health. 2023;20(4):3601.
doi:10.3390/ijerph20043601 .

Šuljagić, Vesna, Đurić-Petković, Danijela, Lazić, Srdan, Mladenović, Jovan, Rakonjac, Bojan, Opačić, Dolores, Ljubenović, Nenad, Milojković, Biljana, Radojević, Katarina, Nenezić, Ivana, Rančić, Nemanja, "Epidemiological Predictors of Positive SARS-CoV-2 Polymerase Chain Reaction Test in Three Cohorts: Hospitalized Patients, Healthcare Workers, and Military Population, Serbia, 2020" in International Journal of Environmental Research and Public Health, 20, no. 4 (2023):3601,
https://doi.org/10.3390/ijerph20043601 . .

TY  - JOUR
AU  - Jovčić, Branko
AU  - Lepsanović, Zorica
AU  - Begović, Jelena
AU  - Rakonjac, Bojan
AU  - Perovanović, Jelena
AU  - Topisirović, Ljubiša
AU  - Kojić, Milan
PY  - 2013
UR  - https://imagine.imgge.bg.ac.rs/handle/123456789/648
UR  - http://intor.torlakinstitut.com/handle/123456789/832
AB  - The genetic context of the bla(NDM-1) gene in the genome of Pseudomonas aeruginosa MMA83 was investigated. Sequencing of the cosmid selected for the bla(NDM-1) gene revealed the presence of two bla(NDM-1) copies in the genome of P. aeruginosa MMA83 in a unique genetic environment. Additionally, mating assays, DNA-DNA hybridization, and an S1 nuclease assay strongly suggest that the blaNDM-1 gene in P. aeruginosa MMA83 is chromosome borne.
PB  - Amer Soc Microbiology, Washington
T2  - Antimicrobial Agents and Chemotherapy
T1  - The Clinical Isolate Pseudomonas aeruginosa MMA83 Carries Two Copies of the bla(NDM-1) Gene in a Novel Genetic Context
EP  - 3407
IS  - 7
SP  - 3405
VL  - 57
DO  - 10.1128/AAC.02312-12
ER  - 

@article{
author = "Jovčić, Branko and Lepsanović, Zorica and Begović, Jelena and Rakonjac, Bojan and Perovanović, Jelena and Topisirović, Ljubiša and Kojić, Milan",
year = "2013",
abstract = "The genetic context of the bla(NDM-1) gene in the genome of Pseudomonas aeruginosa MMA83 was investigated. Sequencing of the cosmid selected for the bla(NDM-1) gene revealed the presence of two bla(NDM-1) copies in the genome of P. aeruginosa MMA83 in a unique genetic environment. Additionally, mating assays, DNA-DNA hybridization, and an S1 nuclease assay strongly suggest that the blaNDM-1 gene in P. aeruginosa MMA83 is chromosome borne.",
publisher = "Amer Soc Microbiology, Washington",
journal = "Antimicrobial Agents and Chemotherapy",
title = "The Clinical Isolate Pseudomonas aeruginosa MMA83 Carries Two Copies of the bla(NDM-1) Gene in a Novel Genetic Context",
pages = "3407-3405",
number = "7",
volume = "57",
doi = "10.1128/AAC.02312-12"
}

Jovčić, B., Lepsanović, Z., Begović, J., Rakonjac, B., Perovanović, J., Topisirović, L.,& Kojić, M.. (2013). The Clinical Isolate Pseudomonas aeruginosa MMA83 Carries Two Copies of the bla(NDM-1) Gene in a Novel Genetic Context. in Antimicrobial Agents and Chemotherapy
Amer Soc Microbiology, Washington., 57(7), 3405-3407.
https://doi.org/10.1128/AAC.02312-12

Jovčić B, Lepsanović Z, Begović J, Rakonjac B, Perovanović J, Topisirović L, Kojić M. The Clinical Isolate Pseudomonas aeruginosa MMA83 Carries Two Copies of the bla(NDM-1) Gene in a Novel Genetic Context. in Antimicrobial Agents and Chemotherapy. 2013;57(7):3405-3407.
doi:10.1128/AAC.02312-12 .

Jovčić, Branko, Lepsanović, Zorica, Begović, Jelena, Rakonjac, Bojan, Perovanović, Jelena, Topisirović, Ljubiša, Kojić, Milan, "The Clinical Isolate Pseudomonas aeruginosa MMA83 Carries Two Copies of the bla(NDM-1) Gene in a Novel Genetic Context" in Antimicrobial Agents and Chemotherapy, 57, no. 7 (2013):3405-3407,
https://doi.org/10.1128/AAC.02312-12 . .